RESEARCH-USE BIOSIMILAR ANTIBODY
Otelixizumab
Monoclonal antibody · IgG1
Otelixizumab (ChAglyCD3) is an anti-human CD3 monoclonal antibody and can be used for the research of type 1 diabetes.
TARGETna
YMonoclonal antibody
CATALOGSC-BS-297
CATALOG NUMBERSC-BS-297
MOLECULAR WEIGHTApprox. 144.58 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Otelixizumab (ChAglyCD3) is an anti-human CD3 monoclonal antibody and can be used for the research of type 1 diabetes.
Otelixizumab is a recombinant research-use antibody directed against na.